These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31928530)

  • 41. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
    Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
    Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer.
    Guo W; Li W; Yuan L; Mei X; Hu W
    Med Sci Monit; 2019 Dec; 25():10122-10128. PubMed ID: 31884511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
    Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
    Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.
    Katsha A; Arras J; Soutto M; Belkhiri A; El-Rifai W
    Mol Oncol; 2014 Dec; 8(8):1419-28. PubMed ID: 24953013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apigetrin inhibits gastric cancer progression through inducing apoptosis and regulating ROS-modulated STAT3/JAK2 pathway.
    Sun Q; Lu NN; Feng L
    Biochem Biophys Res Commun; 2018 Mar; 498(1):164-170. PubMed ID: 29408335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
    He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
    Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells.
    Li S; Cong X; Gao H; Lan X; Li Z; Wang W; Song S; Wang Y; Li C; Zhang H; Zhao Y; Xue Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):6. PubMed ID: 30616627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. STAT3 is associated with lymph node metastasis in gastric cancer.
    Deng J; Liang H; Zhang R; Sun D; Pan Y; Liu Y; Zhang L; Hao X
    Tumour Biol; 2013 Oct; 34(5):2791-800. PubMed ID: 23824569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD24 mediates gastric carcinogenesis and promotes gastric cancer progression via STAT3 activation.
    Wang YC; Wang JL; Kong X; Sun TT; Chen HY; Hong J; Fang JY
    Apoptosis; 2014 Apr; 19(4):643-56. PubMed ID: 24327257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The RNA binding protein neuro-oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA stability to enhance JAK2-STAT3 signaling in CRC.
    Hong YG; Xu GS; Yu GY; Zhou JD; Liu QZ; Ni JS; Yan HL; Zhang W; Hao LQ
    Surg Oncol; 2019 Dec; 31():67-74. PubMed ID: 31541909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
    Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin.
    Yang Y; Zhao Q; Cai Z; Cheng G; Chen M; Wang J; Zhong H
    PLoS One; 2015; 10(5):e0125132. PubMed ID: 25992623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
    World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
    He T; Cui J; Wu Y; Sun X; Chen N
    Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastrin acting on the cholecystokinin2 receptor induces cyclooxygenase-2 expression through JAK2/STAT3/PI3K/Akt pathway in human gastric cancer cells.
    Xu W; Chen GS; Shao Y; Li XL; Xu HC; Zhang H; Zhu GQ; Zhou YC; He XP; Sun WH
    Cancer Lett; 2013 May; 332(1):11-8. PubMed ID: 23376640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KIAA0040 enhances glioma growth by controlling the JAK2/STAT3 signalling pathway.
    He J; Xue K; Fan F; Li L; Rao X; Liu W; Nie C
    J Cell Mol Med; 2024 Apr; 28(8):e18332. PubMed ID: 38661644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
    Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N
    Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.